Compound ID | 188
Class: Quorum-sensing inhibitor
| Spectrum of activity: | Gram-positive |
| Details of activity: | Staphylococcus aureus, invasive skin and soft tissue infections (SSTIs) |
| Institute where first reported: | Department of Pharmaceutical Sciences, College of Pharmacy, University of New Mexico, Albuquerque, New Mexico, USA |
| Year first mentioned: | 2015 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/substance/175266988 |
| Guide to Pharmacology: | ω-Hydroxyemodin |
| Citations: |
|